The Cytel Blog: Perspectives on Enquiry & Evidence

Its important to take a strategic  approach to clinical development  in order to minimize the potential for Phase 3..

The Lung-MAP  trial is an innovative biomarker driven 'precision medicine' study which evaluates five novel agents for..

  Challenge: Our client, an emerging biotechnology company, was preparing for the next stage of development for their..

In order for adaptive designs to reach their potential, it’s critical that knowledge is effectively dissemirnated..

In this blog we’ll highlight some unique challenges that are encountered from a Data Management perspective when..

    Cost of pharmaceutical development and R&D productivity is an ongoing industry concern, consistently discussed in..

On March 16th and 17th the 5th East User Group Meeting took place in London.  This very successful 2 days saw a variety..

MCP-Mod methodology for dose-ranging clinical trials has been gaining popularity since the 2013 publication of the..

Seamless adaptive clinical trials have gained popularity for reducing the projected time it takes to complete the..